Abstract
There is a critical need for equitable access to cell therapies in cancer treatment, particularly within public safety-net healthcare systems that serve minority and socioeconomically disadvantaged populations. We discuss how the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is piloting a cell therapy program aimed at addressing cancer care disparities and has the potential to serve as a national model for enhancing health equity in cancer care.
| Original language | English |
|---|---|
| Pages (from-to) | 2007-2010 |
| Number of pages | 4 |
| Journal | Cancer Cell |
| Volume | 41 |
| Issue number | 12 |
| DOIs |
|
| State | Published - 11 Dec 2023 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Bringing CAR T cell therapy trials to underserved populations'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver